通过EZH2-AKT2介导的微质偏振调节,西格莫伊丁B减轻了与败血症相关的脑病变

Ziyi Wang1, Yafei Liu2, Yuxin Liu3

  • 1Peking University First Hospital, Beijing, PR China; Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, PR China.

Molecular immunology
|August 20, 2025
PubMed
概括

一种新的EZH2降解剂,Sigmoidin B,在传统中医中被确定为与败血症相关的脑病变. 这种天然化合物在治疗毒症模型中的脑损伤和炎症方面具有前景.